Evidence map›Paper›PMID 36288993›Full record

ArticleInternal medicine (Tokyo, Japan)2023

Encapsulating Peritoneal Sclerosis in Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Systemic Sclerosis.

Mayumi Matsuda, Kazuhiro Yokota, Takaya Ichimura, Sakon Sakai, Takashi Maruyama, Takuma Tsuzuki Wada, Yasuto Araki, Yu Funakubo Asanuma, Yuji Akiyama, Atsushi Sasaki and 1 more

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Mayumi MatsudaDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan.
Kazuhiro YokotaDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan.
Takaya IchimuraDepartment of Pathology, Faculty of Medicine, Saitama Medical University, Japan.
Sakon SakaiDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan.
Takashi MaruyamaDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan.
Takuma Tsuzuki WadaDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan.
Yasuto ArakiDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan.
Yu Funakubo AsanumaDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan.
Yuji AkiyamaDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan.
Atsushi SasakiDepartment of Pathology, Faculty of Medicine, Saitama Medical University, Japan.
Toshihide MimuraDepartment of Rheumatology and Applied Immunology, Faculty of Medicine, Saitama Medical University, Japan.
Saitama Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We encountered a 57-year-old Japanese woman with encapsulating peritoneal sclerosis (EPS) in systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic sclerosis. The patient was admitted to our hospital because of ascites retention. Administration of tocilizumab, an anti-interleukin-6 receptor antibody, for her RA reduced the refractory ascites remarkably; however, she developed sudden acute gastrointestinal bleeding and died a year later. On autopsy, sclerotic thickening of the peritoneum showed diffuse infiltration of podoplanin-positive fibroblast-like cells, and a diagnosis of EPS was made. EPS rarely occurs in SLE, and tocilizumab may be a new treatment candidate for EPS.

Indexed as

Arthritis, RheumatoidLupus Erythematosus, SystemicPeritoneal FibrosisScleroderma, SystemicAscitesFemaleHumansMiddle Agedencapsulating peritoneal sclerosispodoplaninrheumatoid arthritissystemic lupus erythematosustocilizumab

Identifiers

PMID36288993
PMCPMC10293004
OpenAlexW4307431232

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.